1216601-32-9
Chemical Structure
Norfloxacin-d8
Synonym(s): MK-0366-d8
- CAS No.: 1216601-32-9
- Formula:C16H10D8FN3O3
- Molecular Weight:327.38
IUPAC Name: 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl-2,2,3,3,5,5,6,6-d8)-1,4-dihydroquinoline-3-carboxylic acid
InChIKey: OGJPXUAPXNRGGI-SQUIKQQTSA-N
SMILES: CCN1C2=CC(N3C([2H])([2H])C([2H])([2H])NC([2H])([2H])C3([2H])[2H])=C(F)C=C2C(C(C(O)=O)=C1)=O
Biological Activity: Norfloxacin-d8 is the deuterium labeled Norfloxacin. Norfloxacin (MK-0366) is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria, which functions by inhibiting DNA gyrase.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Norfloxacin-d8 | Norfloxacin-d8 is the deuterium labeled Norfloxacin. Norfloxacin (MK-0366) is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria, which functions by inhibiting DNA gyrase. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Norfloxacin (Standard) | 99.81% | Norfloxacin (Standard) is the analytical standard of Norfloxacin. This product is intended for research and analytical applications. Norfloxacin (MK-0366) is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria, which functions by inhibiting DNA gyrase. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Norfloxacin-d5 | 99.91% | Norfloxacin-d5 is the deuterium labeled Norfloxacin. Norfloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria, which functions by inhibiting DNA gyrase. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Norfloxacin | 98.31% | Norfloxacin (MK-0366) is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria, which functions by inhibiting DNA gyrase. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||